|
⚲
|
| Keyboard |
| Hefti Franz
✚
|
|
|---|---|
| CIK # | 0001735529 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001735529] | |
| 4 | [0001735529] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Hefti Franz | |
| Prevail Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Prevail Therapeutics Inc PRVL
Stock Option (Right to Buy) · derivative
|
2021-01-22 | Disposed to issuer | 266,895 | $0.00 | |
|
Prevail Therapeutics Inc PRVL
Stock Option (Right to Buy) · derivative
|
2021-01-22 | Disposed to issuer | 59,844 | $0.00 | |
|
Prevail Therapeutics Inc PRVL
Stock Option (Right to Buy) · derivative
|
2021-01-22 | Disposed to issuer | 62,200 | $0.00 | |
|
Prevail Therapeutics Inc PRVL
Stock Option (Right to Buy) · derivative
|
2020-02-19 | Grant | 62,200 | $0.00 |